Treatment patterns and outcomes among patients with EGFR-mutant advanced NSCLC in the frontline and post-osimertinib settings

2022

Sabari J, Pisano S, Gemmler K, Mueller J, Bernabé Caro R, Girard N, Goto K, Leighl N, Ohe Y, Kim TM, Lee S-H, Demirdjian L, Rudolph S, Mahadevia P, Bauml JM, Besse B